07:00 ETAvere Therapeutics Announces $500 Million Private Placement to Support Development of Once-Weekly Oral IL-23 Therapy AVR-001prnewswire·Aug 10 at 06:05 AMNXTC-7.06%
The Market's Island of Misfit Toys: Real Cash, Fake Hype, and SPAC ZombiesGlobal Report·Aug 9 at 04:12 AMCTAS-0.88%IFF-1.59%
Beyond the Hardware: How Wix and Mid-Cap Techs Are Rewriting the AI PlaybookGlobal Report·Aug 8 at 04:20 AMDOCU-3.63%WIX+0.81%
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga_article·Aug 7 at 04:05 PMABCL+1.45%NXTC-7.06%
The Island of Misfit Stocks: From Nestle's Fire Sale to Micro-Cap MergersGlobal Report·Aug 7 at 04:18 AMJMHLY-0.65%NSRGY-2.53%
Beyond the Macro Noise: 10 Under-the-Radar Strategic Shifts This WeekGlobal Report·Aug 6 at 04:15 AMWTW-0.99%HCA+0.47%
ADAR1 Capital Management reports NextCure common share purchase worth $3.59 millionPUBT·Aug 3 at 04:53 PMNXTC-7.06%
Corporate Disclosures Highlight Divergence as AI Infrastructure and Energy Outpace Legacy SectorsGlobal Report·Jul 30 at 04:14 AMFANG+0.86%FRMI-3.52%
NextCure files Form 3 initial beneficial ownership statement for ADAR1 Capital ManagementPUBT·Jul 29 at 05:04 PMNXTC-7.06%
